Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Open - Mississippi State Hospital sole-source notice RFx 3150007008 has a September 30, 2026 at 10:00 AM submission cutoff; the DFA detail page does not state a time zone.Atlas Opportunity Score 25/100
3374-27-R-RFIN-00006 / 3150007008Mississippi

Mississippi State Hospital FDA-Cleared Clozapine Test Kits Sole Source Notice – RFx 3150007008

Mississippi State Hospital has an open sole-source notice for Saladax Biomedical FDA-cleared clozapine assay, calibration, and control kits under Smart No. 3374-27-R-RFIN-00006 / RFx 3150007008. Mississippi DFA lists September 30, 2026 at 10:00 AM as the submission/opening time; the official detail page does not state a time zone. N9+ and Dr. Miltie direct-vendor fit are 0/100 on current verified facts.

FundingQuoted assay cost $2,150 versus $2,600 list price; total procurement quantity and total contract value are not stated in the notice.
DeadlineSeptember 30, 2026 at 10:00 AM (time zone not stated on the Mississippi DFA detail page)
Last verifiedSeptember 28, 2026
Required next actionMonitor the official Mississippi DFA procurement record through the September 30, 2026 at 10:00 AM cutoff and for any later amendment, withdrawal, award, or other authoritative change. Any objection should be based on documented evidence addressing the sole-source basis or a genuinely equivalent FDA-cleared product, consistent with the notice requirements.

Broad Eligibility

This is a proposed sole-source procurement for Saladax Biomedical MyCare Clozapine assay, calibration, and control kits. A person or entity may object only by providing a detailed, documented basis that the commodity is not sole source.

Atlas Analysis

Open Mississippi State Hospital proposed sole-source procurement for FDA-cleared clozapine test kits, posted as RFx 3150007008. The DFA record identifies the opportunity as a sole-source notice and currently shows it as Open. This is procurement intelligence rather than a general grant; any non-incumbent response should be limited to the documented objection/equivalency process provided by the State.

Verification Status

Verified Open. Mississippi DFA lists Smart Number 3374-27-R-RFIN-00006 / RFx 3150007008 as an open Mississippi State Hospital procurement titled Sole Source Notice for FDA-cleared Clozapine Test Kits. The state record shows an advertised date of September 16, 2026 at 10:00 AM and a submission/opening date of September 30, 2026 at 10:00 AM. The state detail page does not state a time zone.

Authoritative Sources

The controlling Mississippi DFA procurement record is available at Mississippi DFA Procurement Details 46502. It identifies Mississippi State Hospital as the agency, Sandy Randle as the procurement contact, and product category 11505 (Biochemicals/Reagents). Mississippi State Hospital separately publishes the signed procurement notice as Notice of Proposed Sole Source Purchase 926-494.

Verified Procurement Scope

Mississippi State Hospital proposes to purchase FDA-cleared Clozapine Test Kits produced by Saladax Biomedical, Inc., including the MyCare Clozapine Assay Kit, MyCare Clozapine Calibration Kit 2, and MyCare Clozapine Control Kit 2 for therapeutic drug monitoring of Clozaril/Clozapine. The hospital states that the Saladax assay is the only FDA-cleared commercially available clozapine test kit compatible with its laboratory complexity and current Vitros 7600 analyzer, and that Saladax is the proprietor of the assay.

Pricing: the notice states a $2,600 list price for the Clozapine assay and a quoted cost of $2,150, described as a 17% discount. The notice does not state a total procurement quantity or total contract value.

Objection process: a person or entity objecting to the sole-source determination must submit a written notice explaining why the commodity is not sole source, with supporting documentation when applicable, to Mississippi State Hospital, c/o Sandy Jordan, Procurement Director, 3550 Highway 468 West, Whitfield, MS 39193, or Sandy.Jordan@msh.ms.gov. The required subject line is Sole Source Objection. The Mississippi DFA record lists September 30, 2026 at 10:00 AM as the submission/opening time; the official DFA detail page does not state a time zone.

Atlas Analysis

Atlas Opportunity Score: 25/100. N9+ Fit Score: 0/100. This is legitimate Mississippi behavioral-health and laboratory procurement intelligence, but the notice is a supplier-specific sole-source determination for Saladax proprietary clozapine testing products. No truthful Dr. Miltie direct-vendor, applicant-partner, or N9+ path is established on the verified facts. Atlas should not file an objection unless a genuinely equivalent FDA-cleared product and supporting evidence are independently verified.

Next Action

Monitor the official Mississippi DFA and Mississippi State Hospital sources through the September 30, 2026 submission window for any amendment, withdrawal, award action, or authoritative change. Do not create a Dr. Miltie pursuit, applicant outreach, CRM Deal, objection package, or submission unless new verified facts establish a legitimate path.

Source verificationOfficial government source · www.ms.govAtlas last verified this record September 28, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗